[go: up one dir, main page]

HUP0000997A2 - Új gyógyszer-kombináció - Google Patents

Új gyógyszer-kombináció

Info

Publication number
HUP0000997A2
HUP0000997A2 HU0000997A HUP0000997A HUP0000997A2 HU P0000997 A2 HUP0000997 A2 HU P0000997A2 HU 0000997 A HU0000997 A HU 0000997A HU P0000997 A HUP0000997 A HU P0000997A HU P0000997 A2 HUP0000997 A2 HU P0000997A2
Authority
HU
Hungary
Prior art keywords
new medicament
medicament combination
combination
phosphatidylcholine
lecithin
Prior art date
Application number
HU0000997A
Other languages
English (en)
Inventor
András Jávor
dr. Paróczai Margit Pellioniszné
Ákosné Székely
Original Assignee
András Jávor
dr. Paróczai Margit Pellioniszné
Ákosné Székely
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by András Jávor, dr. Paróczai Margit Pellioniszné, Ákosné Székely filed Critical András Jávor
Priority to HU0000997A priority Critical patent/HU227182B1/hu
Publication of HU0000997D0 publication Critical patent/HU0000997D0/hu
Priority to DE60124516T priority patent/DE60124516T3/de
Priority to US10/221,043 priority patent/US20040006048A1/en
Priority to PCT/HU2001/000027 priority patent/WO2001070206A2/en
Priority to EP01914069A priority patent/EP1272197B2/en
Publication of HUP0000997A2 publication Critical patent/HUP0000997A2/hu
Publication of HUP0000997A3 publication Critical patent/HUP0000997A3/hu
Publication of HU227182B1 publication Critical patent/HU227182B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A gyógyszer-kombináció 10,00-99,99 tömeg%-ban L-a-foszfatidilkolinttartalmazó lecitin és aszkorbinsav hatóanyagoknak az 1:1-30:1tömegarányú keveréke, mely egészséges és beteg emberek fizikai ésszellemi teljesítőképességének a megőrzésére és fokozására alkalmas. Ó
HU0000997A 2000-03-06 2000-03-06 Lecitin-ascorbic acid combination HU227182B1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
HU0000997A HU227182B1 (en) 2000-03-06 2000-03-06 Lecitin-ascorbic acid combination
DE60124516T DE60124516T3 (de) 2000-03-06 2001-03-01 Kombination des lezithins mit ascorbinsäure
US10/221,043 US20040006048A1 (en) 2000-03-06 2001-03-01 Combination of lecithin with ascorbic acid
PCT/HU2001/000027 WO2001070206A2 (en) 2000-03-06 2001-03-01 Combination of lecithin with ascorbic acid
EP01914069A EP1272197B2 (en) 2000-03-06 2001-03-01 Combination of lecithin with ascorbic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0000997A HU227182B1 (en) 2000-03-06 2000-03-06 Lecitin-ascorbic acid combination

Publications (4)

Publication Number Publication Date
HU0000997D0 HU0000997D0 (en) 2000-05-28
HUP0000997A2 true HUP0000997A2 (hu) 2002-11-28
HUP0000997A3 HUP0000997A3 (en) 2007-05-02
HU227182B1 HU227182B1 (en) 2010-09-28

Family

ID=89978147

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000997A HU227182B1 (en) 2000-03-06 2000-03-06 Lecitin-ascorbic acid combination

Country Status (5)

Country Link
US (1) US20040006048A1 (hu)
EP (1) EP1272197B2 (hu)
DE (1) DE60124516T3 (hu)
HU (1) HU227182B1 (hu)
WO (1) WO2001070206A2 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002232616A1 (en) * 2000-10-31 2002-06-11 Colgate-Palmolive Company Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin C or vitamin E for preventing or inhibiting loss of cognitive function
EP1350435B1 (en) 2002-04-05 2010-12-22 Societe Des Produits Nestle S.A. Compositions and methods for promoting lipid assimilation in pets
DE10217557A1 (de) * 2002-04-19 2003-11-06 Degussa Bioactives Gmbh Funktionsnahrungsmittel enthaltend eine Phospholipid-haltige stabile Matrix
US20070141223A1 (en) * 2005-12-16 2007-06-21 Solae, Llc Phospholipid-stabilized oxidizable material
DE102006056783A1 (de) * 2006-12-01 2008-06-05 Lts Lohmann Therapie-Systeme Ag Zubereitung zur transdermalen Verabreichung von Galanthamin
IL191123A0 (en) * 2008-04-28 2009-02-11 Meir Shinitzky Composition comprising phospholipids in combination with ascorbic acid and cosmetic products comprising it
US20140141066A1 (en) * 2012-11-20 2014-05-22 Lipo Naturals Llc Encapsulated Ascorbic Acid Composition
CN110404049A (zh) * 2019-07-23 2019-11-05 张明 通过雾化吸入防治心脑血管病和老年痴呆的组合物及应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1176916B (it) * 1984-10-10 1987-08-18 Elvira Pistolesi Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
CH676470A5 (hu) * 1988-02-03 1991-01-31 Nestle Sa
JPH02265457A (ja) † 1989-04-04 1990-10-30 Nikken Food Kk 頭脳栄養補助食品
US5077069A (en) * 1991-01-07 1991-12-31 Kabi Pharmacia Ab Composition of natural antioxidants for the stabilization of polyunsaturated oils
US5223285A (en) † 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
IL110139A0 (en) * 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
CZ281571B6 (cs) † 1993-11-23 1996-11-13 Alois Doc. Ing. Drsc. Nováček Způsob výroby přípravku na bázi lecithinu
MX9605144A (es) † 1994-04-01 1997-12-31 Abbott Lab Producto nutritivo para el tratamiento de la colitis ulcerativa y uso del mismo.
CN1096421A (zh) † 1994-04-25 1994-12-21 刘瑞和 健脑复方蛋白糖
KR0178559B1 (ko) † 1994-11-05 1999-03-20 최진호 두뇌활성제 연질캡슐의 제조방법
KR0148462B1 (ko) † 1995-01-14 1998-11-02 최진호 두뇌활성제 연질캡슐의 제조방법
JPH1094382A (ja) † 1996-09-20 1998-04-14 Otsuka Yakuhin Kogyo Kk ステビア濃縮液配合による健脳食の製造方法
US6130244A (en) † 1998-02-25 2000-10-10 Abbott Laboratories Product and method to reduce stress induced immune suppression
US6048846A (en) † 1998-02-26 2000-04-11 Cochran; Timothy M. Compositions used in human treatment
US6180139B1 (en) * 1998-12-04 2001-01-30 Viva America Marketing, Inc. Composition and method for treating nonalcoholic steatohepatitis

Also Published As

Publication number Publication date
WO2001070206A3 (en) 2002-08-29
DE60124516D1 (de) 2006-12-28
DE60124516T3 (de) 2012-06-06
EP1272197B1 (en) 2006-11-15
WO2001070206B1 (en) 2002-09-26
HU227182B1 (en) 2010-09-28
EP1272197A2 (en) 2003-01-08
DE60124516T2 (de) 2007-10-04
EP1272197B2 (en) 2012-03-28
US20040006048A1 (en) 2004-01-08
HU0000997D0 (en) 2000-05-28
HUP0000997A3 (en) 2007-05-02
WO2001070206A2 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
HUP0203176A2 (hu) Szimetikont tartalmazó orális, szilárd adagolási forma
HUP9901674A2 (hu) Új gyógyszerkombináció
ES2162927T3 (es) Formulacion para la aplicacion por inhalacion.
EA200600598A1 (ru) Лекарственные формы замедленного высвобождения
NO332857B1 (no) Inhalasjonskapsel samt anvendelse av slike
ECSP034883A (es) Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que las contienen
BR0308927A (pt) Comprimido mastigável de sabor agradável
Hersh et al. Local anesthetic mortality: report of case
WO2006108692A3 (en) Dosage form for oral administration of a vitamin
HUP0000997A2 (hu) Új gyógyszer-kombináció
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
UY27759A1 (es) Combinaciones de medicamentos que contienen compuestos heterocíclicos y un nuevo agente anticolinérgico.
WO2005053658A8 (fr) Capsule molle de butylphthalide et procede de preparation correspondant
HUP0002346A1 (hu) Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítmény
HUP9802716A2 (hu) Fájdalomcsillapító gyógyszerkombináció
MXPA04001912A (es) Aminobenzofenonas novedosas.
DE60108227D1 (de) Verwendung von morinda citrifolia zur behandlung von tinnitus
Newell et al. Nitrite inhalants: Historical perspective
EA200501252A1 (ru) Липосомальная композиция, способ ее получения и лекарственное средство на ее основе (варианты)
HUP0401798A2 (hu) Rosuvastatin alkalmazása demencia előtti állapotokban használható gyógyszerkészítmény előállítására
BRPI0513806A (pt) composição medicinal contendo remédio para diabetes
DE58909886D1 (de) Kamillendroge und ihre Verwendung zur Herstellung von Kamillenextrakten, Kamillenöl und pharmazeutischen Mitteln
ATE261732T1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
ATE485058T1 (de) Zusammensetzung enthaltend eine kombination aus einem ppar-alpha, pravastatin und polyglykolisiertem glyzerid
Soto et al. Evaluating novel protein phosphatase 2A activators as therapeutics for cigarette smoke induced loss of lung function

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees
NF4A Restoration of patent protection